Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Coeptis Therapeutics Holdings, Inc. (COEP)

Compare
9.25
-0.42
(-4.34%)
At close: 4:00:02 PM EDT
9.25
0.00
(0.00%)
After hours: 4:56:09 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for COEP

Recent News: COEP

View More
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline

Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
GlobeNewswire 27 days ago
COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan

COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
GlobeNewswire last month
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing

COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
GlobeNewswire last month
Coeptis Therapeutics (COEP): Launching AI-Focused Venture Arm to Fuel Innovation

Coeptis Therapeutics (COEP): Launching AI-Focused Venture Arm to Fuel Innovation
Insider Monkey last month
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups

COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups
GlobeNewswire last month
Coeptis Therapeutics Holdings, Inc. (COEP) Raises $10M to Advance AI-Driven Cell Therapy Innovations

Coeptis Therapeutics Holdings, Inc. (COEP) Raises $10M to Advance AI-Driven Cell Therapy Innovations
Insider Monkey last month
COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration

COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration
PR Newswire last month
Coeptis Therapeutics Holdings, Inc. (COEP): Pioneering AI-Powered Marketing for Healthcare Innovation

Coeptis Therapeutics Holdings, Inc. (COEP): Pioneering AI-Powered Marketing for Healthcare Innovation
Insider Monkey 2 months ago
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation

Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
PR Newswire 2 months ago
Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation

Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation
PR Newswire 2 months ago
Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2)
PR Newswire 2 months ago
View More

Related Tickers

PTIXW Protagenic Therapeutics, Inc.
0.0019
-36.67%
 
TCBWF TC Biopharm (Holdings) Plc
0.0026
0.00%
 
APLMW Apollomics, Inc.
0.0080
-25.93%
 
CEROW CERo Therapeutics Holdings, Inc.
0.0117
-20.95%
 
GDTC CytoMed Therapeutics Limited
2.3800
+0.42%
 
SLRX Salarius Pharmaceuticals, Inc.
0.7197
+1.22%
 
KTTA Pasithea Therapeutics Corp.
1.2100
-4.72%
 
ESLA Estrella Immunopharma, Inc.
0.8500
-3.41%
 
VINC Vincerx Pharma, Inc.
0.5899
-2.51%
 
BIXT Bioxytran, Inc.
0.1750
+19.05%